These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23973499)

  • 21. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
    Dälken B; Giesübel U; Knauer SK; Wels WS
    Cell Death Differ; 2006 Apr; 13(4):576-85. PubMed ID: 16179940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of a humanized single-chain variable fragment antibody targeting chronic myeloid leukemia cells in Escherichia coli and its characterization.
    Zhu X; Wang D; Li S; Xiao Q; Tao K; Hu J; Cao W; Feng W
    Int J Mol Med; 2012 May; 29(5):939-45. PubMed ID: 22322313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
    Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
    Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel PSCA targeting scFv-fusion proteins for diagnosis and immunotherapy of prostate cancer.
    Kessler C; Pardo A; Tur MK; Gattenlöhner S; Fischer R; Kolberg K; Barth S
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):2025-2038. PubMed ID: 28667390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fully human targeted cytotoxic fusion proteins: new anticancer agents on the horizon.
    Weidle UH; Georges G; Brinkmann U
    Cancer Genomics Proteomics; 2012; 9(3):119-33. PubMed ID: 22593247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B.
    Cheung LH; Zhao Y; Alvarez-Cienfuegos A; Mohamedali KA; Cao YJ; Hittelman WN; Rosenblum MG
    J Exp Clin Cancer Res; 2019 Jul; 38(1):332. PubMed ID: 31362764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression, purification and anticancer analysis of GST-tagged human perforin and granzyme B proteins in human laryngeal cancer Hep-2 cells.
    Li X; Zhang G; An G; Liu S; Lai Y
    Protein Expr Purif; 2014 Mar; 95():38-43. PubMed ID: 24291445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
    Woitok M; Klose D; Niesen J; Richter W; Abbas M; Stein C; Fendel R; Bialon M; Püttmann C; Fischer R; Barth S; Kolberg K
    Cancer Lett; 2016 Oct; 381(2):323-30. PubMed ID: 27502168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel CD19-directed recombinant bispecific antibody derivative with enhanced immune effector functions for human leukemic cells.
    Kellner C; Bruenke J; Stieglmaier J; Schwemmlein M; Schwenkert M; Singer H; Mentz K; Peipp M; Lang P; Oduncu F; Stockmeyer B; Fey GH
    J Immunother; 2008; 31(9):871-84. PubMed ID: 18833000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface charge-modification prevents sequestration and enhances tumor-cell specificity of a recombinant granzyme B-TGFα fusion protein.
    Jabulowsky RA; Oberoi P; Bähr-Mahmud H; Dälken B; Wels WS
    Bioconjug Chem; 2012 Aug; 23(8):1567-76. PubMed ID: 22759275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Hydra HALT-1 as a toxin moiety for recombinant immunotoxin.
    Jiemy WF; Hiew LF; Sha HX; In LLA; Hwang JS
    BMC Biotechnol; 2020 Jun; 20(1):31. PubMed ID: 32552895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Construction, expression and characterization of the fusion gene of super-antigen SEA and single chain Fv of the ND-1 monoclonal antibody against human colorectal cancer].
    Chen H; Li L; Fang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr; 28(4):400-3. PubMed ID: 22482412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETA') is a potent immunotoxin against a Hodgkin-derived cell line.
    Klimka A; Barth S; Matthey B; Roovers RC; Lemke H; Hansen H; Arends JW; Diehl V; Hoogenboom HR; Engert A
    Br J Cancer; 1999 Jun; 80(8):1214-22. PubMed ID: 10376974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
    Suck G; Branch DR; Smyth MJ; Miller RG; Vergidis J; Fahim S; Keating A
    Exp Hematol; 2005 Oct; 33(10):1160-71. PubMed ID: 16219538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin.
    Zhao X; Yu Z; Dai W; Yao Z; Zhou W; Zhou W; Zhou J; Yang Y; Zhu Y; Chen S; Cao L
    Biotechnol Appl Biochem; 2011; 58(6):405-11. PubMed ID: 22172103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering a CD123xCD3 bispecific scFv immunofusion for the treatment of leukemia and elimination of leukemia stem cells.
    Kuo SR; Wong L; Liu JS
    Protein Eng Des Sel; 2012 Oct; 25(10):561-9. PubMed ID: 22740616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cytotoxic protease granzyme M is expressed by lymphocytes of both the innate and adaptive immune system.
    de Koning PJ; Tesselaar K; Bovenschen N; Colak S; Quadir R; Volman TJ; Kummer JA
    Mol Immunol; 2010 Jan; 47(4):903-11. PubMed ID: 19896187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
    Repp R; Kellner C; Muskulus A; Staudinger M; Nodehi SM; Glorius P; Akramiene D; Dechant M; Fey GH; van Berkel PH; van de Winkel JG; Parren PW; Valerius T; Gramatzki M; Peipp M
    J Immunol Methods; 2011 Oct; 373(1-2):67-78. PubMed ID: 21855548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating antigen-specific cytotoxicity of CD8+ T cells in fish by granzyme B-like activity.
    Toda H; Yabu T; Shiba H; Moritomo T; Nakanishi T
    Vet Immunol Immunopathol; 2011 May; 141(1-2):168-72. PubMed ID: 21435730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.